1,231 results on '"Grützmann, Robert"'
Search Results
152. Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data from Three Randomized Controlled Trials
153. Nonductal Primary Malignancies of the Pancreas: Acinus Cell Carcinoma
154. CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
155. Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
156. Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction; a retrospective analysis from experienced single center.
157. The outcome of patients with inflammatory bowel disease–associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer–a matched-pair analysis of survival
158. Novel Criteria for Intratumoral Budding with Prognostic Relevance for Colon Cancer and Its Histological Subtypes
159. Operationsindikationen bei Tumoren der Bauchspeicheldrüse
160. Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study
161. Whole genomes redefine the mutational landscape of pancreatic cancer
162. RREB1::MRTFB fusion‐positive extra‐glossal mesenchymal neoplasms: A series of five cases expanding their anatomic distribution and highlighting significant morphological and phenotypic diversity.
163. Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator.
164. Analysis of DNA Methylation in Pancreatic Cancer: An Update
165. A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI – Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results
166. Long-Term Follow-Up of Patients Receiving Neoadjuvant Treatment Modalties for Soft Tissue Sarcomas of the Extremities
167. Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot
168. Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross‐sectional results of a German multicentre observational study (PROSa)
169. Molecular profiles and clinical outcome of stage UICC II colon cancer patients
170. RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system
171. Quality of Life in Patients After Pancreaticoduodenectomy for Chronic Pancreatitis
172. Pancreatic Heterotopia of the Duodenum: Anatomic Anomaly or Clinical Challenge?
173. Functional analysis of LOXL2 in pancreatic carcinoma
174. PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition
175. Pancreatic Acinar Cell Carcinoma: A Multi-institutional Study
176. Outcome of Invasive and Noninvasive Intraductal Papillary-Mucinous Neoplasms of the Pancreas (IPMN): A 10-year Experience
177. Targeting DNA damage response and replication stress in pancreatic cancer
178. Neoadjuvant Therapy for Resectable Pancreatic Cancer
179. Pyloruserhaltende partielle Pankreatoduodenektomie mit segmentaler Pfortaderresektion
180. Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
181. Lipomatous Solitary Fibrous Tumors Harbor Rare NAB2-STAT6 Fusion Variants and Show Up-Regulation of the Gene PPARG, Encoding for a Regulator of Adipocyte Differentiation
182. Operationsindikationen bei Tumoren der Bauchspeicheldrüse.
183. Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based Variants
184. The health-related quality of life of sarcoma patients and survivors in germany—cross-sectional results of a nationwide observational study (PROSa)
185. Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: cross-sectional results of a German multicentre observational study (PROSa)
186. Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better?: A Large International Population-based Cohort Study
187. Contributors
188. Gene Expression Profiling in Pancreatic Cancer
189. Epidemiology, Treatment, and Outcome of Pancreatic Cancer
190. Precision Oncology in Surgery
191. Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes
192. Gene Expression in Solitary Fibrous Tumors (SFTs) Correlates with Anatomic Localization and NAB2-STAT6 Gene Fusion Variants
193. Proposal of a Standardized Questionnaire to Structure Clinical Peer Reviews of Mortality and Failure of Rescue in Pancreatic Surgery
194. Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
195. Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal and intra-abdominal sarcomas: Feasibility, efficacy, toxicity and long-term outcome
196. Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects
197. Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives
198. Prospective evaluation of ultrasound and colour duplex imaging for the assessment of surgical resectability of pancreatic tumours
199. Gene expression profiles of microdissected pancreatic ductal adenocarcinoma
200. DNA Methylation in Pancreatic Cancer: Protocols for the Isolation of DNA and Bisulfite Modification
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.